GSP Crop Science IPO GMP: Initial Subscription Rates and Key Details

GSP Crop Science is a research-focused agrochemical company engaged in the development and manufacturing of insecticides, herbicides, fungicides, and plant growth regulators. The company has recently launched its initial public offering (IPO), which is open for subscription from March 16 to March 18, 2026. The IPO price band is set between ₹304 and ₹320 per share, aiming to raise a total of ₹400 crore. This amount includes ₹160 crore reserved for Offer for Sale (OFS) and ₹240 crore through fresh shares.

As of the first day of the IPO, the shares are trading at par, with the GSP Crop Science IPO GMP reported at ₹0. By 2:54 PM on Day 1, the overall subscription rate stood at 0.41 times, indicating a moderate level of interest from investors. The retail portion of the IPO was filled only 0.07 times, while the Non-Institutional Investors (NII) segment saw a subscription rate of 0.19 times. In contrast, the Qualified Institutional Buyers (QIB) segment was more active, with a subscription rate of 1.19 times.

The lot size for the IPO comprises 46 company shares, making it accessible for various types of investors. The company plans to utilize ₹170 crore of the proceeds from the IPO for debt reduction, which is a significant step towards improving its financial health. As of September 2025, GSP Crop Science reported a net profit of ₹81.07 crore on a total income of ₹847.61 crore for the first half of FY26, indicating a stable financial performance leading up to the IPO.

The most likely date for share allocation is March 19, 2026, with the IPO proposed for listing on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). Observers are anticipating that the listing will occur on March 23, 2026, which will provide a clearer picture of how the market values GSP Crop Science post-IPO.

Initial reactions from market analysts suggest that the varied subscription rates across different segments may reflect investor sentiment towards the agrochemical sector. While institutional investors have shown interest, retail investors appear to be more cautious. This could be attributed to broader market conditions or specific concerns regarding the agrochemical industry.

As the IPO progresses, it will be crucial to monitor the subscription rates in the coming days, particularly in the retail segment, which is often seen as a barometer of public interest in a company’s prospects. The overall success of the IPO will depend on how well GSP Crop Science can communicate its growth strategy and address investor concerns.

In summary, GSP Crop Science’s IPO is a significant event in the financial markets, with the company aiming to strengthen its balance sheet and expand its operations. The upcoming days will reveal more about investor confidence and the potential for future growth in the agrochemical sector.